Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma

10.1159/000518619

Saved in:
Bibliographic Details
Main Authors: Ng K.Y.Y., Tan S.H., Tan J.J.E., Tay D.S.H., Lee A.W.X., Ang A.J.S., Wong L.W.J., Choo S.P., Tai D.W.-M., Lee J.J.X.
Other Authors: DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Format: Article
Published: S. Karger AG 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/214278
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-214278
record_format dspace
spelling sg-nus-scholar.10635-2142782023-10-31T20:48:37Z Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma Ng K.Y.Y. Tan S.H. Tan J.J.E. Tay D.S.H. Lee A.W.X. Ang A.J.S. Wong L.W.J. Choo S.P. Tai D.W.-M. Lee J.J.X. DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) Hepatocellular carcinoma; Immune checkpoint inhibitors; Immune-related adverse events; Survival; Response 10.1159/000518619 Liver Cancer 2022-01-25T09:37:08Z 2022-01-25T09:37:08Z 2021-10-26 Article Ng K.Y.Y., Tan S.H., Tan J.J.E., Tay D.S.H., Lee A.W.X., Ang A.J.S., Wong L.W.J., Choo S.P., Tai D.W.-M., Lee J.J.X. (2021-10-26). Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer. ScholarBank@NUS Repository. https://doi.org/10.1159/000518619 2235-1795 1164-5553 https://scholarbank.nus.edu.sg/handle/10635/214278 Attribution-NonCommercial 4.0 International http://creativecommons.org/licenses/by-nc/4.0/ S. Karger AG Karger 2021
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Hepatocellular carcinoma; Immune checkpoint inhibitors; Immune-related adverse events; Survival; Response
spellingShingle Hepatocellular carcinoma; Immune checkpoint inhibitors; Immune-related adverse events; Survival; Response
Ng K.Y.Y.
Tan S.H.
Tan J.J.E.
Tay D.S.H.
Lee A.W.X.
Ang A.J.S.
Wong L.W.J.
Choo S.P.
Tai D.W.-M.
Lee J.J.X.
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
description 10.1159/000518619
author2 DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
author_facet DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Ng K.Y.Y.
Tan S.H.
Tan J.J.E.
Tay D.S.H.
Lee A.W.X.
Ang A.J.S.
Wong L.W.J.
Choo S.P.
Tai D.W.-M.
Lee J.J.X.
format Article
author Ng K.Y.Y.
Tan S.H.
Tan J.J.E.
Tay D.S.H.
Lee A.W.X.
Ang A.J.S.
Wong L.W.J.
Choo S.P.
Tai D.W.-M.
Lee J.J.X.
author_sort Ng K.Y.Y.
title Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
title_short Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
title_full Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
title_fullStr Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
title_full_unstemmed Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
title_sort impact of immune-related adverse events on efficacy of immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma
publisher S. Karger AG
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/214278
_version_ 1781792980179353600